scholarly article | Q13442814 |
P356 | DOI | 10.1111/TMI.12759 |
P8608 | Fatcat ID | release_gpt5iw6l3bfwpdporrqjn3aawu |
P698 | PubMed publication ID | 27458720 |
P2093 | author name string | Brian D Wright | |
Kaela Colwell | |||
Yolanda Hernando | |||
P2860 | cites work | Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts | Q21562239 |
Avermectins, New Family of Potent Anthelmintic Agents: Producing Organism and Fermentation | Q24598202 | ||
Corporate social responsibility in global health: an exploratory study of multinational pharmaceutical firms | Q26864474 | ||
The Mectizan Donation Program: 20 years of successful collaboration - a retrospective | Q28291428 | ||
Ivermectin, 'wonder drug' from Japan: the human use perspective | Q34598257 | ||
The Mectizan Donation Program - highlights from 2005. | Q35103932 | ||
Economic evaluation of Mectizan distribution | Q35743781 | ||
The life and times of ivermectin - a success story | Q35954279 | ||
History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents | Q37951025 | ||
15 years of APOC--a lifetime of public health evidence | Q38870072 | ||
Mectizan Donation Program: evaluation of a public-private partnership | Q40517998 | ||
Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis. | Q50536507 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | shareholder | Q381136 |
P304 | page(s) | 1304-1310 | |
P577 | publication date | 2016-07-26 | |
P1433 | published in | Tropical Medicine and International Health | Q15765747 |
P1476 | title | Doing well while fighting river blindness: the alignment of a corporate drug donation programme with responsibilities to shareholders | |
P478 | volume | 21 |
Q90234620 | Economic evaluations of onchocerciasis interventions: a systematic review and research needs | cites work | P2860 |
Search more.